Results 101 to 110 of about 50,727 (310)

Assessing a speaker for fast speech in unit selection speech synthesis

open access: yes, 2009
Moers D, Wagner P. Assessing a speaker for fast speech in unit selection speech synthesis. In: Proceedings of Interspeech. 2009: 2071-2074.This paper describes work in progress concerning the ad- equate modeling of fast speech in unit selection speech ...
Wagner, Petra ; https://orcid.org/   +1 more
core  

[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich   +19 more
wiley   +1 more source

Prosody Disruptor for Voice Protection Against Unauthorized Speech Synthesis

open access: yesIEEE Access
Recent advances in neural speech synthesis enable highly realistic speech generation, raising concerns about unauthorized voice impersonation. To prevent this, proactive voice protection introduces imperceptible perturbations into speech signals that ...
Seoyoung Park   +3 more
doaj   +1 more source

Linguistic and Mixed Excitation Improvements on a HMM-based speech synthesis for Castilian Spanish [PDF]

open access: yes, 2007
HiddenMarkov Models based text-to-speech(HMM-TTS)synthesis is one of the techniques for generating speech from trained statistical models where spectrum and prosody of basic speech units are modelled altogether.
Socoró Carrié, Joan Claudi   +4 more
core  

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree   +9 more
wiley   +1 more source

Sine-wave windowed synthesis

open access: yesArchives of Acoustics, 2014
Speech can be understood even when a 3-tone replica of speech is presented to a listener. In tonal synthesis, called sine-wave synthesis (SWS), the output signal consists of number of time-varying sinusoids that follow center frequencies and amplitudes
Hanna Gardzielewska, T. Kaczmarek
doaj  

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy